Latest From Biotech Now

Couldn’t Make it to San Francisco This Week?

20070112

Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare Conference. Before arriving, hopefully you read the survival guide put forth by the InVivo blog team. In it, Chris Morrison and team outlined a few helpful talking points to help you when running in to industry colleagues. Likewise, Luke Timmerman, from Xconomy, has all the industry news you need to know heading in to the event, perhaps most importantly; who he thinks should Read More >

Business and Investments, Events  |  1 Comment  |  Email This Post
Tags: , , , , ,

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Emerging-Companies115x76

Innovative biotech companies at all stages of the development process are working toward next generation technologies to heal, fuel, and feed the world. In an effort to highlight promising policy legislation and its impact on the biotech sector, BIO has authored the following white paper: The Future Policy Landscape for Emerging Biotechnology Companies. Many research-intensive companies rely on private investment to support their groundbreaking R&D. Therefore, favorable legislation such as the JOBS Act is essential Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

TPP and IP: The Economic Benefits of a Pacific Trade Agreement

scientists115x76

Ndp Analytics recently published a study on the economic benefits of intellectual property rights (IP) in the Trans-Pacific Partnership. They find that 2/3’s of the “economic benefits for the U.S. economy and the 11 partner countries would come from IP-intensive manufacturing industries.” They conclude that “the stronger the protection of IP rights under the TPP, the greater the value of trade leading to greater economic growth, additional jobs created, higher incomes, and development across countries.” Here Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

New York Times Reveals True Motives For Hawaii’s GMO Ban

admin-ajax-115x76

Making front page news, the New York Times on January 4, 2014 ran an in-depth and well-researched piece by Amy Harmon on the long-running legislative battle in Hawaii over genetically modified organisms (GMOs). The article titled “A Lonely Quest for Facts on Genetically Modified Crops,” details how Councilman Greggor Ilagan saw beyond the false unscientific claims of the anti-GMO activists and voted against a ban on cultivation of GMOs. Harmon describes Ilagan’s tireless efforts to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patently Biotech’s Top Articles of 2013

lab_tech02-thumb

Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions, and other developments around the world captured headlines. Here are Patently Biotech’s top blog posts written in 2013 by number of views. 1.   Myriad Supreme Court Decision: BIO’s Statement 2.  Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished 3.  What a Patent is Not 4.  Gene Patents, Angelina Jolie, and Reality 5.  What OxyContin Tells Us About Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,